Effect of vitamin D receptor gene alleles on bone loss in early rheumatoid arthritis

Journal of Rheumatology

Volumn 25, Issue 5, 1998, Pages 864-868

  Gough, Andrew ^a   Sambrook, Philip ^b   Devlin, Joe ^c   Lilley, John ^d   Huisoon, Aarnoud ^c   Betteridge, Joan ^c   Franklyn, Jayne ^c   Nguyen, Tuan ^b   Morrison, Nigel ^b   Eisman, John ^b   Emery, Paul ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Bone density; Genotype; Osteoporosis; Rheumatoid arthritis; Vitamin D receptor

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RECEPTOR GENE; RHEUMATOID ARTHRITIS; VITAMIN D METABOLISM;

ALLELES; ARTHRITIS, RHEUMATOID; BONE DENSITY; FEMALE; GENETIC MARKERS; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, CALCITRIOL;

EID: 0031944339     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ng KC, Revell A, Beer M, Boucher BJ, Cohen RD, Currey HLF. Incidence of metabolic bone disease in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1984;43:370-7.
2. Mellish RWE, O'Sullivan MM, Garrahan NJ, Compston JE. Iliac crest trabecular bone mass and structure in patients with non-steroid treated rheumatoid arthritis. Ann Rheum Dis 1987;46:830-6.
3. Sambrook PN, Eisman J, Champion GD, Yeates MG, Pocock NA, Eberl S. Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 1987;30:721-8.
4. Magro M, Tricerri A, Piane D, et al. Generalised osteoporosis in non-steroid treated rheumatoid arthritis. Rheumatol Int 1991;1:73-6.
5. Sambrook PN, Shawe D, Hesp R, et al. Rapid periarticular bone loss in rheumatoid arthritis. Arthritis Rheum 1990;33:615-22.
6. Kroger H, Honkanen R, Saarikoski S, Alhava E. Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis - a population study. Ann Rheum Dis 1994;53:18-23.
7. Sambrook PN, Spector TD, Seeman E, et al. Osteoporosis in rheumatoid arthritis: a monozygotic co-twin control study. Arthritis Rheum 1995;38:806-9.
8. Hooyman JR, Melton LJ, Nelson AM, O'Fallon WM, Riggs BL. Fractures after rheumatoid arthritis. Arthritis Rheum 1984;27: 1353-61.
9. Cooper C, Coupland C, Mitchell M. Rheumatoid Arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995; 54:49-52.
10. Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ 1993;306:558.
11. Beat AM, Bloch DA, Fries JF. Predictors of fractures in early rheumatoid arthritis. J Rheumatol 1991;18:804-8.
12. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
13. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284-7.
14. Yamagata Z, Miyamura T, Iijima S, et al. Vitamin D receptor gene polymorphism and bone mineral density in healthy Japanese women. Lancet 1994;344:1027.
15. Spector TD, Keen RW, Arden NK, et al. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ 1995;310:1357-60.
16. Fleet JC, Harris SS, Wood RJ, Dawson-Hughes B. The Bsm1 vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women. J Bone Miner Res 1995;10:985-90.
17. Riggs BL, Nguyen TV, Melton LJ, et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res 1995; 10:991-6.
18. Krall EA, Parry P, Lichter JB, Dawson-Hughes B. Vitamin D receptor alleles and rates of bone loss: influences of years since menopause and calcium intake. J Bone Miner Res 1995;10:978-84.
19. Salamone LM, Ferrell R, Black DM, et al. The association between vitamin D receptor gene polymorphisms and bone mineral density at the spine, hip and total body in premenopausal women. Osteoporosis Int 1996;6:63-8.
20. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
21. Ritchie DM, Boyle JA, McInnes JM, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;37:393-406.
22. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
23. Fries JF. The dimensions of health outcomes: the Health Assessment Questionnaire. J Rheumatol 1982;74:786-93.
24. Gough A, Faint J, Salmon M, et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994;38:1166-70.
25. Lilley J, Walters BG, Heath DA, Drolc Z. In vivo and in vitro precision for bone density measured by dual energy x-ray absorption. Osteoporosis Int 1991;1:141-6.
26. Sainz J, Van Tornout JM, Loro L, Sayre J, Roe TF, Gilsanz V. Vitamin D receptor gene polymorphisms and bone density in prepubertal Amerian girls of Mexican descent. N Engl J Med 1997;337:77-82.
27. 3 inhibits proliferative response of T and B lymphocytes in serum free culture. Int J Immunopharmacol 1987;9:719-23.
28. 3 receptors in lymphocytes from patients with rheumatoid arthritis. J Lab Clin Med 1986;108: 596-600.
29. Mawer EB, Hayes ME, Still PE, et al. Evidence for non-renal synthesis of 1,25-dihydroxyvitamin D3 in patients with inflammatory arthritis. J Bone Miner Res 1991;6:733-9.
30. Howard G, Nguyen T, Morrison N, et al. Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab 1995;80: 2800-5.
31. Van der Heijde DMFM, van Riel PLCM, van Rijswijk MH, van der Putte LBA. Influence of prognostic factors on the final outcome in rheumatoid arthritis. Semin Arthritis Rheum 1988;17:284-92.
32. Hustmyer FG, Peacock M, Hui S, Johnston CC, Christian JC: Bone mineral density in relation to polymorphisms at the vitamin D receptor locus. J Clin Invest 1994;94:2130-4.
33. Looney JE, Yoon HK, Fischer M, et al. Lack of a high prevalence of the BB vitamin D receptor genotype in severely osteoporotic women. J Clin Endocrinol Metab 1995;80:2158-62.
34. Garnero P, Borel O, Sornay-Rendu E, Delmas PD. Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women. J Bone Miner Res 1995;10:1283-8.
35. Keen RW, Major PJ, Lanchbury JS, Spector TD. Vitamin D receptor gene polymorphism and bone loss. Lancet 1995;345:990.
36. Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour J-P. Vitamin D receptor gene polymorphisms and change in lumbar spine bone mineral density. Lancet 1995;345:423.
37. Kiel DP, Myers RH, Cupples LA, et al. The BsmI vitamin D receptor restriction fragment lengh polymorphism (bb) influences the effect of calcium intake on bone mineral density. J Bone Miner Res 1997;12:1049-57.